← Leaderboards
Oxana G Palesh
Virginia Commonwealth University
$12,298,975
Attributed
$15,854,782
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,854,782 · 7
By mechanism
R01$13,504,904 · 4
T32$1,289,713 · 1
K07$679,009 · 1
R21$381,156 · 1
Top collaborators
- Shelli R Kesler14 shared
- Bernard F. Fuemmeler3 shared
- Karen M Mustian2 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Shelli R Kesler$7,903,167
Others in their field
Top investigators on “Chemotherapy”
- George R Seage · Abt Associates, Inc.$223,371,661
- Charles A Coltman · Southwest Oncology Group$170,244,220
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$154,566,243
- Philip J Disaia · University Of California Irvine$115,055,799
- Norman Wolmark · Nsabp Foundation, Inc.$106,367,723
Research focus
ChemotherapyQuality Of LifeMalignant Breast NeoplasmMalignant NeoplasmsAffectWomanReportingAttentionCancer TherapyMorbidity - Disease RateMedicalBaseCancer PatientCognitiveDesignSleep DisturbancesSleeplessnessBehavior TherapySymptomsSleepLinkIncidenceRandomizedSeverities
Grant awards (39)
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia$940,691
R01 · FY2025 · CA · contact PI
Training Program in Cancer Prevention and Control$463,858
T32 · FY2025 · CA
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia$913,823
R01 · FY2024 · CA · contact PI
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$488,028
R01 · FY2024 · CA
Training Program in Cancer Prevention and Control and Cancer Health Equity (CPC-CHE)$349,915
T32 · FY2024 · CA
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2)$312,611
R01 · FY2024 · CA · contact PI
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia$597,603
R01 · FY2023 · CA · contact PI
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$500,546
R01 · FY2023 · CA
Training Program in Cancer Prevention and Control and Cancer Health Equity (CPC-CHE)$475,940
T32 · FY2023 · CA
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2)$315,171
R01 · FY2023 · CA · contact PI
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$535,294
R01 · FY2022 · CA
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2)$204,589
R01 · FY2022 · CA · contact PI
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors$135,815
R01 · FY2022 · CA · contact PI
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia$1
R01 · FY2022 · CA · contact PI
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia$1
R01 · FY2022 · CA · contact PI
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia$892,934
R01 · FY2021 · CA · contact PI
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$281,784
R01 · FY2021 · CA
Efficacy of Brief Behavioral Therapy for Cancer-Related Insomnia in Reducing Headache Burden: Exploring Patient Phenotypes and Predictors of Response$202,096
R01 · FY2021 · CA · contact PI
Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia$920,121
R01 · FY2020 · CA · contact PI
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$612,633
R01 · FY2020 · CA
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors$335,114
R01 · FY2020 · CA · contact PI
Predicting Long-Term Chemotherapy-Related Cognitive Impairment$645,700
R01 · FY2019 · CA
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors$338,233
R01 · FY2019 · CA · contact PI
Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors$287,435
R01 · FY2019 · CA · contact PI
Brief Behavioral Intervention for Insomnia During Chemotherapy$611,633
R01 · FY2018 · CA · contact PI
Brief Behavioral Intervention for Insomnia During Chemotherapy$599,744
R01 · FY2017 · CA · contact PI
Brief Behavioral Intervention for Insomnia During Chemotherapy$608,740
R01 · FY2016 · CA · contact PI
Prefrontal cortex abnormalities associated with breast cancer chemotherapy$325,775
R01 · FY2016 · CA · contact PI
RCT for Mechanisms and Management of Sleep Utilizing Multicenter Clinical Oncology Network$170,801
R21 · FY2016 · CA · contact PI
Brief Behavioral Intervention for Insomnia During Chemotherapy$597,418
R01 · FY2015 · CA · contact PI
Prefrontal cortex abnormalities associated with breast cancer chemotherapy$325,775
R01 · FY2015 · CA · contact PI
RCT for Mechanisms and Management of Sleep Utilizing Multicenter Clinical Oncology Network$210,355
R21 · FY2015 · CA · contact PI
Brief Behavioral Intervention for Insomnia During Chemotherapy$659,594
R01 · FY2014 · CA · contact PI
Prefrontal cortex abnormalities associated with breast cancer chemotherapy$316,002
R01 · FY2014 · CA · contact PI
Management of Insomnia in Cancer Patients$135,837
K07 · FY2012 · CA · contact PI
Management of Insomnia in Cancer Patients$135,837
K07 · FY2011 · CA · contact PI
Management of Insomnia in Cancer Patients$135,837
K07 · FY2010 · CA · contact PI
Management of Insomnia in Cancer Patients$135,837
K07 · FY2009 · CA · contact PI
Management of Insomnia in Cancer Patients$135,661
K07 · FY2008 · CA · contact PI